CryoCor Ablation For Atrial Flutter Is Approvable With Conditions – Panel
This article was originally published in The Gray Sheet
Executive Summary
CryoCor's cryoablation system is approvable for treatment of isthmus-dependent atrial flutter, FDA's Circulatory System Devices Panel concluded in an 8-2 vote June 27
You may also be interested in...
CryoCor Plans Launch After Gaining Approval For Cryoablation System
CryoCor plans to begin marketing its cryoablation system for atrial flutter over the next several months, the firm announced Aug. 2
CryoCor Plans Launch After Gaining Approval For Cryoablation System
CryoCor plans to begin marketing its cryoablation system for atrial flutter over the next several months, the firm announced Aug. 2
CryoCor’s Cryoablation System For Atrial Flutter Is Non-Approvable, FDA Says
CryoCor is planning to amend its PMA after receiving a non-approvable letter from FDA for its CryoCor cardiac cryoablation system for the treatment of atrial flutter, according to CEO Greg Ayers, MD